A highly personalized approach from a team of leading oncology experts
Urologic malignancies include tumors of the prostate, bladder, kidneys, adrenal glands, and testicles. Maimonides Cancer Center treats them all. At every step, our patients receive close attention from a multidisciplinary team of specialists who work together to deliver superior care.
This care includes the most up-to-the-minute treatments and procedures, such as high-intensity focal ultrasound (HIFU), advanced radiation therapies, chemotherapy treatment, cryoablation (freezing and destroying cancer cells), and robotic-assisted laparoscopic surgery. We use laparoscopic techniques for the vast majority of urologic procedures to minimize trauma, speed recovery, and reduce hospital stays. Our specialists also conduct clinical research, so our patients have access to state-of-the-art therapies that are not widely available elsewhere.
Dr. Silver on KevinMD Podcast – An Update on Prostate Cancer Treatment
“Maimonides is at the forefront of minimally invasive, multidisciplinary surgical and medical care, offering men facing a diagnosis of prostate cancer the most advanced technology and the most personalized and customized treatment options available.”
David Silver, MD Chief, Division of Urology Director, Prostate Center
Maimonides Prostate Center
Our approach to care
Of all urologic malignancies, prostate cancer is the most common, affecting about 1 in 7 men. When caught early and limited to the gland, prostate cancer is highly treatable. Even when the disease spreads outside of the prostate, our specialists offer a number of effective treatment options. The Maimonides Prostate Center is the only full-service prostate center in Brooklyn. We have the latest diagnostic technologies, breakthrough therapies, and a team of experts known for achieving the best results and preserving the quality of life for our patients.
Risk factors for prostate cancer include:
- Age – Your chances of developing prostate cancer go up after you turn 50
- Ethnicity – African American men are more likely to develop prostate cancer than white, Latino, and Asian men
- Family history – Having a father or brother with prostate cancer doubles your risk
- Genetics – Inherited gene mutations may increase the odds of having prostate cancer
Screening and diagnosis
Prostate cancer grows slowly and causes few, if any, noticeable symptoms. So, it’s important to know your risk factors and have regular prostate cancer screenings. Prompt and accurate diagnosis is key to designing and starting the right treatment plan.
We use the latest screening and diagnostic tools, including:
- Digital rectal examination
- Magnetic resonance imaging (MRI)-ultrasound fusion-guided biopsy
- Positron emission tomography (PET) scans
- Prostate-specific antigen (PSA) blood test
Our state-of-the-art treatments
Chemotherapy, hormone therapy, and other medications
These options include androgen deprivation (hormone) therapy and chemotherapy. We also offer immunotherapy for cancer that has spread to other parts of the body and doesn’t respond to other treatments.
Our experts participate in national clinical trials to investigate new treatment options for prostate cancer. You may be eligible for an alternative therapy to treat cancer or relieve treatment side effects.
High-intensity focal ultrasound (HIFU)
HIFU uses energy from high-frequency sound waves to destroy cancer cells. We are the first center on the East Coast to offer the next generation focal HIFU for gland-sparing treatment — the world’s most advanced noninvasive ablation device for prostate cancer. Focal HIFU is the latest innovation in this technology, allowing for precise treatment, zeroing in on just the cancerous tumor. This treatment targets only the cancerous part of the prostate, sparing the rest of the healthy gland.
We offer several different radiation therapies, including internal radiation (brachytherapy) and external beam radiation, including 3D conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT), and image-guided radiation therapy (IGRT). We’re among a few centers nationwide offering an injectable form of radiation to treat prostate cancer that has spread to bones.
Our specialists use minimally-invasive and robotic technology to surgically remove the prostate, with help from the da Vinci® Xi surgical system. Benefits of minimally-invasive procedures, include tiny incisions, reducing blood loss, infection risk, scarring, and postoperative pain. This advanced technology enhances precision and leads to better outcomes.
Maimonides Medical Center is the first hospital in Brooklyn to offer NanoKnife technology for prostate cancer surgery. Unlike traditional methods, this revolutionary approach enables surgeons to precisely target and eliminate diseased tissue without harming healthy tissue like blood vessels. Patients now have access to targeted therapy with minimal side effects, as this minimally-invasive technique doesn’t require a surgical incision, heat or radiation. Additionally, NanoKnife technology can be used close to sensitive areas like the muscles involved in urinary control, with a minimal risk of incontinence.
Meet the 1st HIFU Patient on the East Coast – Pasquale Santoro
Maimonides is among the few hospitals in Brooklyn using an advanced treatment called Xofigo® to treat prostate cancer that has spread to the bones and is resistant to hormone therapy